• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION RANGER PACLITAXEL-COATED PTA BALLOON CATHETER; DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION RANGER PACLITAXEL-COATED PTA BALLOON CATHETER; DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER Back to Search Results
Model Number 1973-03
Medical Device Problem Code Material Rupture (1546)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 08/12/2022
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that a balloon rupture occurred.The 99% stenosed target lesion was located in a severely tortuous and severely calcified superficial femoral artery.A 6.0 x 60mm, 80cm ranger paclitaxel-coated pta balloon catheter was selected to treat the severe limb ischemia in the endovascular treatment procedure.However, during the first inflation at 10 atmospheres for 2 seconds duration, the balloon ruptured vertically.After decompression, the device was removed from the body and the procedure was completed with another device of the same model.There were no patient complications reported.
 
Additional Manufacturer Narrative
Initial reporter province- (b)(6).
 
Additional Manufacturer Narrative
E1: initial reporter province- (b)(6).Device evaluated by mfr.: returned product consisted of a ranger drug coated balloon catheter.The outer shaft, inner shaft, balloon and tip were visually and microscopically examined.Visual examination revealed no damages.Microscopic examination revealed a pinhole in 15mm from the tip.Inspection of the remainder of the device presented no other damage or irregularities.Product analysis confirmed there is a pinhole in the balloon.
 
Event or Problem Description
It was reported that a balloon rupture occurred.The 99% stenosed target lesion was located in a severely tortuous and severely calcified superficial femoral artery.A 6.0 x 60mm, 80cm ranger paclitaxel-coated pta balloon catheter was selected to treat the severe limb ischemia in the endovascular treatment procedure.However, during the first inflation at 10 atmospheres for 2 seconds duration, the balloon ruptured vertically.After decompression, the device was removed from the body and the procedure was completed with another device of the same model.There were no patient complications reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RANGER PACLITAXEL-COATED PTA BALLOON CATHETER
Common Device Name
DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
HEMOTEQ AG
adenauerstrasse 15
wuerselen 52146
GM   52146
Manufacturer Contact
jay johnson
4100 hamline ave n
arden hills, MN 55112
6515810888
MDR Report Key15341922
Report Number2124215-2022-33714
Device Sequence Number19965669
Product Code ONU
UDI-Device Identifier08714729976110
UDI-Public08714729976110
Combination Product (Y/N)Y
Initial Reporter CountryJA
PMA/510(K) Number
P190019
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative,Distributor
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 04/06/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date01/04/2024
Device Model Number1973-03
Device Catalogue Number1973-03
Device Lot Number00036H22
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 08/12/2022
Supplement Date Received by Manufacturer03/17/2023
Initial Report FDA Received Date09/01/2022
Supplement Report FDA Received Date04/06/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured01/04/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-